Trials / Completed
CompletedNCT01775423
A Study of BBI608 in Adult Patients With Advanced Malignancies
A Phase I Clinical Study of BBI608 in Adult Patients With Advanced Malignancies
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Sumitomo Pharma America, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, single arm, dose escalation study of BBI608 in patients with advanced malignancies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BBI608 |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2015-08-06
- Completion
- 2015-08-06
- First posted
- 2013-01-25
- Last updated
- 2023-11-14
Locations
3 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT01775423. Inclusion in this directory is not an endorsement.